Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections

Simone Giuliano, Antonio D'Avolio, Jacopo Angelini, Amedeo de Nicolò, Sara Ferin, Camilla Martino, Luca Martini, Maria Merelli, Francesco Russiani, Carlo Tascini, Manjunath P. Pai

Open source

DOI
10.1016/j.ijantimicag.2026.107943
Published
2026-11
Container
International Journal of Antimicrobial Agents
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijantimicag.2026.107943,
  title = {Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections},
  author = {Simone Giuliano and Antonio D'Avolio and Jacopo Angelini and Amedeo de Nicolò and Sara Ferin and Camilla Martino and Luca Martini and Maria Merelli and Francesco Russiani and Carlo Tascini and Manjunath P. Pai},
  year = {2026},
  journal = {International Journal of Antimicrobial Agents},
  doi = {10.1016/j.ijantimicag.2026.107943},
  url = {https://doi.org/10.1016/j.ijantimicag.2026.107943}
}

RIS

TY  - JOUR
TI  - Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections
AU  - Simone Giuliano
AU  - Antonio D'Avolio
AU  - Jacopo Angelini
AU  - Amedeo de Nicolò
AU  - Sara Ferin
AU  - Camilla Martino
AU  - Luca Martini
AU  - Maria Merelli
AU  - Francesco Russiani
AU  - Carlo Tascini
AU  - Manjunath P. Pai
PY  - 2026
JO  - International Journal of Antimicrobial Agents
DO  - 10.1016/j.ijantimicag.2026.107943
UR  - https://doi.org/10.1016/j.ijantimicag.2026.107943
ER  - 

APA

Giuliano, S., D'Avolio, A., Angelini, J., Nicolò, A. D., Ferin, S., Martino, C., Martini, L., Merelli, M., Russiani, F., Tascini, C., & Pai, M. P. (2026). Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2026.107943

Source records